SLNO

Soleno Therapeutics Inc · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website oleno.life
Employees(FY) 25
ISIN US8342033094

Performance

-2.38%

-12.76%

-14.32%

+7.83%

+12.25%

YTD

+25.47%

Profile

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

Advanced Technical Analysis

Technical Analysis of SLNO 2024-12-20

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 3 indicating strong downward pressure, while the Oscillators Score of 50 suggests a neutral stance. The Technical Score of 26 further reinforces the bearish outlook, indicating that caution is warranted in the current market environment.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of SLNO

Stock Rank

Recent News & Updates

2024-12-17 16:31
Soleno Therapeutics Gets $200 Million Debt Financing From Oxford Finance(MT Newswires)
2024-12-17 16:05
Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC(GlobeNewswire)
2024-12-17 03:05
Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC(Globenewswire)
2024-11-27 09:02
High Growth Tech Stocks to Watch in November 2024(Simply Wall St.)
2024-11-27 08:00
Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference(GlobeNewswire)
2024-11-27 05:38
Kronos, Idorsia plan layoffs; PTC shelves ALS drug(BioPharma Dive)
2024-11-26 19:00
Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference(Globenewswire)
2024-11-26 18:40
FDA delays decision of Solenos Prader-Willi syndrome drug(Yahoo Finance)
2024-11-26 10:08
Soleno Tumbles 17% as FDA Extends Review Timeline for Prader-Willi Treatment(GuruFocus.com)
2024-11-26 09:03
Soleno Therapeutics Says FDA Extends DCCR NDA Review Citing 'Major Amendment'(MT Newswires)
2024-11-26 08:30
Soleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome(GlobeNewswire)
2024-11-25 19:30
Soleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome(Globenewswire)
2024-11-14 16:05
Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024(GlobeNewswire)
2024-11-14 03:05
Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024(Globenewswire)
2024-11-12 05:38
Here's Why We're Not At All Concerned With Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Situation(Simply Wall St.)
2024-11-06 16:05
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results(GlobeNewswire)
2024-10-28 08:00
Soleno Therapeutics to Participate in Upcoming November Investor Conferences(GlobeNewswire)
2024-10-27 20:00
Soleno Therapeutics to Participate in Upcoming November Investor Conferences(Globenewswire)
2024-10-25 14:44
Lamb Weston, Adecoagro, and More Stocks See Action From Activist Investors(Barrons.com)
2024-10-21 08:00
Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D.(GlobeNewswire)
2024-10-20 20:00
Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D.(Globenewswire)
2024-10-18 18:41
TriMas, Soleno Therapeutics, Ring Energy, and More Stocks See Action From Activist Investors(Barrons.com)
2024-10-16 08:44
Soleno Therapeutics (SLNO): Pioneering Treatment for Prader-Willi Syndrome with DCCR(Insider Monkey)
2024-10-15 18:10
Soleno Therapeutics (SLNO): Breakthroughs in Prader-Willi Syndrome Treatment(Insider Monkey)
2024-10-10 19:04
Carlyle Group Inc.'s Strategic Reduction in Soleno Therapeutics Inc.(GuruFocus.com)
2024-10-09 09:33
SLNO Stock Rises on Upbeat Regulatory Update on PWS Drug NDA(Zacks)
2024-10-08 18:29
Why Soleno Therapeutics Stock Blasted 9% Higher Today(Motley Fool)
2024-10-08 09:12
Soleno Therapeutics Says US FDA Determines NDA for DCCR Does Not Need Advisory Panel Meeting for Now(MT Newswires)
2024-10-08 08:30
Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome(GlobeNewswire)
2024-10-07 20:30
Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome(Globenewswire)

Page 1 of 8

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.